Collectively, these verdicts indicated that depression neuropathology is linked with RAS over‐activity, and selective inhibition of AngII/AT1 or activation of AngII/AT2 and AngII/Ang1‐7/MASR could be a therapeutic way for attenuating depression. Here, AGTR1 is linked to depressive symptom measurement.